ES2044534T3 - Un metodo para la preparacion de una composicion tromboliticamente activa. - Google Patents

Un metodo para la preparacion de una composicion tromboliticamente activa.

Info

Publication number
ES2044534T3
ES2044534T3 ES90850008T ES90850008T ES2044534T3 ES 2044534 T3 ES2044534 T3 ES 2044534T3 ES 90850008 T ES90850008 T ES 90850008T ES 90850008 T ES90850008 T ES 90850008T ES 2044534 T3 ES2044534 T3 ES 2044534T3
Authority
ES
Spain
Prior art keywords
active composition
thrombolitically
preparation
treating
thrombotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90850008T
Other languages
English (en)
Inventor
Gunnar Pohl
Christer Mattsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of ES2044534T3 publication Critical patent/ES2044534T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

COMPUESTO TROMBOLITICAMENTE ACTIVO QUE CONSTA DE UNA COMBINACION DE UN ACTIVADOR PLASMINOGENICO (T-PA) MODIFICADO DE TIPO TISSUE COMO COMPONENTE PRINCIPAL Y DE UN TPA HUMANO NORMAL, ESTREPTOQUINASA O UROQUINASA HUMANA, COMO COMPONENTE SECUNDARIO EN UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE. UNMETODO PARA TRATAR UN TRANSTORNO TROMBOTICO, Y UN KIT O PAQUETE MEDICINAL PARA SU EMPLEO EN EL TRATAMIENTO DE TRANSTORNOS TROMBOTICOS.
ES90850008T 1989-01-10 1990-01-08 Un metodo para la preparacion de una composicion tromboliticamente activa. Expired - Lifetime ES2044534T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900067A SE462829B (sv) 1989-01-10 1989-01-10 Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas

Publications (1)

Publication Number Publication Date
ES2044534T3 true ES2044534T3 (es) 1994-01-01

Family

ID=20374707

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90850008T Expired - Lifetime ES2044534T3 (es) 1989-01-10 1990-01-08 Un metodo para la preparacion de una composicion tromboliticamente activa.

Country Status (11)

Country Link
US (1) US5202121A (es)
EP (1) EP0381640B1 (es)
JP (1) JP2958650B2 (es)
AT (1) ATE80308T1 (es)
AU (1) AU624466B2 (es)
CA (1) CA2007075C (es)
DE (1) DE69000290T2 (es)
DK (1) DK0381640T3 (es)
ES (1) ES2044534T3 (es)
GR (1) GR3006053T3 (es)
SE (1) SE462829B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682733B1 (en) * 1987-06-18 2004-01-27 Roche Diagnostics, Gmbh Fibrinolytic enzymes
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US5830468A (en) * 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins
PT84589B (en) * 1986-04-02 1989-05-09 Beecham Group Plc Process for preparing a fibrinolytic enzyme
NL8701021A (nl) * 1987-04-29 1988-11-16 Stichting Centraal Lab Humane t-pa(u-pa) substitutie-mutant eiwitten, daarvoor coderend recombinant dna, getransfecteerde gastheercellen, bereiding van de mutant eiwitten, en farmaceutische preparaten.
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen

Also Published As

Publication number Publication date
DE69000290D1 (de) 1992-10-15
CA2007075C (en) 2002-03-19
CA2007075A1 (en) 1990-07-10
DK0381640T3 (da) 1992-12-21
EP0381640A1 (en) 1990-08-08
SE8900067D0 (sv) 1989-01-10
AU4776890A (en) 1990-08-30
EP0381640B1 (en) 1992-09-09
ATE80308T1 (de) 1992-09-15
SE462829B (sv) 1990-09-10
SE8900067A (es) 1989-01-10
DE69000290T2 (de) 1993-04-22
JPH02225420A (ja) 1990-09-07
JP2958650B2 (ja) 1999-10-06
AU624466B2 (en) 1992-06-11
GR3006053T3 (es) 1993-06-21
US5202121A (en) 1993-04-13

Similar Documents

Publication Publication Date Title
HK184896A (en) Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine
AU4135289A (en) Pharmaceutically active combination
EP0714435A4 (en) PRO-UROKINASES OBTAINED BY MUTATION
EP0211592A3 (en) Pharmaceutical dosage unit
AU2036188A (en) New tissue plasminogen activator
NO20021501L (no) Fibrinolyttisk aktivt polypeptid
ES2044534T3 (es) Un metodo para la preparacion de una composicion tromboliticamente activa.
NO941561L (no) Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning
EP0208785A4 (en) FIBRINOPHILER UROKINASE COMPLEX AND THEIR PRODUCTION.
ES2039194T3 (es) Un metodo de preparar una composicion farmaceutica tromboliticamente activa.
AU2353688A (en) Modified tissue plasminogen activator
DE59001558D1 (de) Thrombolytisch wirkendes kombinationspraeparat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381640

Country of ref document: ES